Verona Pharma plc (VRNA)
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
Address
3 MORE LONDON RIVERSIDE
LONDON, X0 SE1 2RE
Founded
2005
Number of Employees
79
Website
http://www.veronapharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at VRNA make a trade.
Creating a free account takes less than one minute